Biotech

R&D

Biotech trends in COVID era: the pharmaphorum podcast

In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical compa

Events

Partner Content

Online Live Team Pharma Forecasting Training Now Available

Working remotely can have its challenges, why not get together for a fun and rewarding learning experience and refresh your forecasting skills?

News

Catamaran joins the CAR-NK fleet, raising $42m in first roun...

Catamaran Bio has weighed anchor with a $42 million first-round financing that will be used to pull its off-the-shelf natural killer (NK) cell therapies for cancer through early-stage devel

News

VC firm SR One completes GSK spin-out, raising $500m

Trans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund with $500m in its coffers.

Events

Partner Content

TGFB for Immuno-Oncology Drug Development Summit

Are you interested in finding the next breakthrough in immuno-oncology preclinical or clinical development?

News

New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gen

Biotech trends in COVID era: the pharmaphorum podcast

Online Live Team Pharma Forecasting Training Now Available

Catamaran joins the CAR-NK fleet, raising $42m in first roun...

VC firm SR One completes GSK spin-out, raising $500m

TGFB for Immuno-Oncology Drug Development Summit

New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Biotech

Editor's Picks